Chelation Therapy螯合疗法

Chelating (pronounced key-layting) agents are substances which can chemically bond with, or chelate (from the Greek chele, claw), metals, minerals, or chemical toxins from the body. 螯合（突出重点layting ）代理商的物质，可以在化学上的债券，或螯合（从希腊chele ，爪） ，金属，矿物，化学或身体排毒。 The chelating agent actually encircles a mineral or metal ion and carries it from the body via the urine and feces. 该螯合剂，其实包围矿物或金属离子，并进行它从体内经由尿液和粪便。 Many organic acids found in the body or in foods can act as chelating agents, including acetic acid, ascorbic acid (vitamin C), citric acid, and lactic acid. 许多有机酸，发现在该机构或在食品中可以作为螯合剂，包括乙酸，抗坏血酸（维生素 C ） ，柠檬酸，乳酸。 Natural chelation processes in the body are responsible for such things as the digestion, assimilation, and transport of food nutrients, the formation of enzymes and hormones, and detoxification of toxic chemicals and metals. 天然螯合过程中，机构的负责这类事情，作为消化，吸收，运输和食物的养分，形成酶和激素，以及戒毒有毒化学品和金属。

Intravenous chelation therapy involves injecting the chelating agent EDTA into the bloodstream for the purpose of eliminating from the body undesirable substances such as heavy metals, chemical toxins, mineral deposits, and fatty plaques (as in the arteries; the agent binds to the calcium in the plaques). 静脉注射螯合疗法涉及注射螯合剂的EDTA进入血液，以便消除从体内不良物质，如重金属，化学毒素，矿藏，与脂肪斑块（如在动脉;代理人绑定到钙，在斑块） 。 EDTA (ethylene diamine tetraacetic acid) is an effective and widely studied chelating agent. 的EDTA （乙二胺四乙酸）是一种有效的和广泛的研究螯合剂。 It cannot chelate mercury, however, DMSA and DMPS, the chemicals which work intravenously to chelate mercury, are not approved by the FDA. 它不能螯合汞，不过， dmsa和dmps ，化学品，其中静脉注射工作，以螯合汞，都没有通过FDA的。

EDTA is a synthetic amino acid (amino acids are the building blocks of protein) and is approximately one third as toxic to the body as aspirin. 的EDTA是一种合成氨基酸（氨基酸是大厦的蛋白质）和大约三分之一作为毒性身体阿司匹林。 Chelation therapy with EDTA was first introduced into medicine in the United States in 1948 as a treatment for the lead poisoning of workers in a battery factory. 螯合疗法的EDTA与中首次引入到中医药在美国在1948年作为一种治疗铅中毒的工人在一个电池工厂。 Shortly thereafter, the US Navy advocated chelation for sailors who had absorbed lead while painting government ships and facilities. 此后不久，美海军主张螯合为水手谁吸收铅的同时，绘画政府的船舶和设施。 The FDA approved IV EDTA chelation as a treatment for lead poisoning. FDA批准四的EDTA螯合作为一种治疗铅中毒。

Physicians administering the chelation for lead toxicity observed that patients who also had atherosclerosis (fatty-plaque buildup on arterial walls) or arteriosclerosis (hardening of the arteries) experienced reductions in both conditions after chelation. 医师管理螯合铅毒性指出，谁的病人也有动脉粥样硬化（脂肪酸斑块建设对动脉壁）或动脉粥样硬化（硬化的动脉）经历了减少在这两个条件后，螯合。 Since 1952, IV EDTA chelation has been used to treat cardiovascular disease. 自1952年以来，四的EDTA螯合已用于治疗心血管疾病。

Over 1,800 scientific journal articles have been published on the use of EDTA in intravenous (IV) chelation. 超过1800年的科学杂志的文章已发表了关于使用的EDTA在静脉注射（四）螯合。 In the past 30 years, hundreds of thousands of patients have received this therapy, as delivered by over 1,000 physicians in approximately 3,300,000 IV infusions. 在过去30年来，数以十万计的患者已经收到此治疗方法，发表了超过1000医师在大约3300000四，输液。 EDTA’s success rate in increasing blood circulation is 82%, provided the patients received sufficient chelation. 的EDTA的成功率在增加血液循环，是 82 ％ ，所提供的病人得到足够的螯合。